Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Perl

Showing results (341-350 of 570) with videos related to

Pageof 57
Sort By:
JAMA|March 7, 2001
Botulinum toxin as a biological weapon: medical and public health managementS S Arnon, R Schechter, T V Inglesby, et al.
JAMA|September 4, 2019
N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel: A Randomized Clinical TrialLewis J Radonovich, Michael S Simberkoff, Mary T Bessesen, et al.
Emerging Infectious Diseases|February 24, 2021
Transmission of Antimicrobial-Resistant Staphylococcus aureus Clonal Complex 9 between Pigs and Humans, United StatesPranay R Randad, Jesper Larsen, Hülya Kaya, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 7, 2024
Socioeconomic Disparities and the Prevalence of Antimicrobial ResistanceLauren N Cooper, Alaina M Beauchamp, Tanvi A Ingle, et al.
Astrobiology|July 8, 2025
Structural Biosignatures-A Category of Potential Biosignatures in the Life Detection Knowledge BaseSvetlana Shkolyar, Leslie Bebout, Jennifer G Blank, et al.
The New England Journal of Medicine|June 21, 2013
Hospital outbreak of Middle East respiratory syndrome coronavirusAbdullah Assiri, Allison McGeer, Trish M Perl, et al.
JAMA|June 21, 2001
Tularemia as a biological weapon: medical and public health managementD T Dennis, T V Inglesby, D A Henderson, et al.
The Journal of Infectious Diseases|January 6, 2007
Improving methicillin-resistant Staphylococcus aureus surveillance and reporting in intensive care unitsSusan S Huang, Sheryl L Rifas-Shiman, David K Warren, et al.
JAMA|May 12, 2000
Plague as a biological weapon: medical and public health management. Working Group on Civilian BiodefenseT V Inglesby, D T Dennis, D A Henderson, et al.
Open Forum Infectious Diseases|August 14, 2023
Risk Factors for SARS-CoV-2 Infection and Severe Outcomes Among People With Human Immunodeficiency Virus: Cohort StudyJohn J Hanna, Liyu B Geresu, Marlon I Diaz, et al.
Pageof 57

Showing results (341-350 of 570) with videos related to

Sort By:
Pageof 57
JAMA|March 7, 2001
Botulinum toxin as a biological weapon: medical and public health managementS S Arnon, R Schechter, T V Inglesby, et al.
JAMA|September 4, 2019
N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel: A Randomized Clinical TrialLewis J Radonovich, Michael S Simberkoff, Mary T Bessesen, et al.
Emerging Infectious Diseases|February 24, 2021
Transmission of Antimicrobial-Resistant Staphylococcus aureus Clonal Complex 9 between Pigs and Humans, United StatesPranay R Randad, Jesper Larsen, Hülya Kaya, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 7, 2024
Socioeconomic Disparities and the Prevalence of Antimicrobial ResistanceLauren N Cooper, Alaina M Beauchamp, Tanvi A Ingle, et al.
Astrobiology|July 8, 2025
Structural Biosignatures-A Category of Potential Biosignatures in the Life Detection Knowledge BaseSvetlana Shkolyar, Leslie Bebout, Jennifer G Blank, et al.
The New England Journal of Medicine|June 21, 2013
Hospital outbreak of Middle East respiratory syndrome coronavirusAbdullah Assiri, Allison McGeer, Trish M Perl, et al.
JAMA|June 21, 2001
Tularemia as a biological weapon: medical and public health managementD T Dennis, T V Inglesby, D A Henderson, et al.
The Journal of Infectious Diseases|January 6, 2007
Improving methicillin-resistant Staphylococcus aureus surveillance and reporting in intensive care unitsSusan S Huang, Sheryl L Rifas-Shiman, David K Warren, et al.
JAMA|May 12, 2000
Plague as a biological weapon: medical and public health management. Working Group on Civilian BiodefenseT V Inglesby, D T Dennis, D A Henderson, et al.
Open Forum Infectious Diseases|August 14, 2023
Risk Factors for SARS-CoV-2 Infection and Severe Outcomes Among People With Human Immunodeficiency Virus: Cohort StudyJohn J Hanna, Liyu B Geresu, Marlon I Diaz, et al.
Pageof 57